Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Pancreatic Cancer Action Network

Headquarters: Manhattan Beach, CA, United States of America
Year Founded: 1999
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Jul 31, 2024
Product Development

Clinical Report: BioNTech claims mRNA cancer vaccine success

Plus data from NewAmsterdam, Pfizer, Calliditas, Ventyx and Viking
BioCentury | Sep 3, 2021
Management Tracks

Civetta picks Roberts as CEO

Plus, management moves at Crinetics, OraSure, Silence, Avacta, Oncternal and more
BioCentury | Oct 17, 2020
Product Development

How the PanCAN master protocol could promote innovation in pancreatic cancer

With the launch of Precision Promise, pancreatic cancer is the latest indication to secure an adaptive platform trial 
BioCentury | Apr 26, 2019
Product Development

For patients’ sake, collaborate already

Editor’s Commentary: How and where industry can collaborate on cancer immunotherapy platform trials
BioCentury | Mar 23, 2019
Tools & Techniques

A frequentist and a Bayesian walk into a trial

How Bayesian methods are gaining ground in frequentist-dominated clinical trials
BioCentury | Mar 15, 2019
Product Development

Broadening the PARP playing field

How the PARP field is mapping out new synthetic lethality plays
BioCentury | Sep 21, 2018
Tools & Techniques

Precision for pancreatic cancer

How new tumor profiling methods could bring precision to pancreatic cancer
BioCentury | Jan 11, 2018
Translation in Brief

Quality over quantity

MSKCC team finds a neoantigen formula for pancreatic cancer
Items per page:
1 - 10 of 16